What is the share price of Veerhealth Care Ltd (VEERHEALTH) today?
The share price of VEERHEALTH as on 11th March 2025 is ₹12.52. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Veerhealth Care Ltd (VEERHEALTH) share?
The past returns of Veerhealth Care Ltd (VEERHEALTH) share are- Past 1 week: 2%
- Past 1 month: -31.82%
- Past 3 months: -29.21%
- Past 6 months: -44.24%
- Past 1 year: -39.11%
- Past 3 years: 135.16%
- Past 5 years: 272.97%
What are the peers or stocks similar to Veerhealth Care Ltd (VEERHEALTH)?
The peers or stocks similar to Veerhealth Care Ltd (VEERHEALTH) include:What is the market cap of Veerhealth Care Ltd (VEERHEALTH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Veerhealth Care Ltd (VEERHEALTH) is ₹26.22 Cr as of 11th March 2025.What is the 52 week high and low of Veerhealth Care Ltd (VEERHEALTH) share?
The 52-week high of Veerhealth Care Ltd (VEERHEALTH) is ₹27 and the 52-week low is ₹9.29.What is the PE and PB ratio of Veerhealth Care Ltd (VEERHEALTH) stock?
The P/E (price-to-earnings) ratio of Veerhealth Care Ltd (VEERHEALTH) is 65.55. The P/B (price-to-book) ratio is 1.20.Which sector does Veerhealth Care Ltd (VEERHEALTH) belong to?
Veerhealth Care Ltd (VEERHEALTH) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Veerhealth Care Ltd (VEERHEALTH) shares?
You can directly buy Veerhealth Care Ltd (VEERHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Veerhealth Care Ltd
VEERHEALTHVeerhealth Care Ltd
VEERHEALTH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹26 cr, stock is ranked 3,956
High RiskStock is 3.95x as volatile as Nifty
12.524.50% (-0.59)
12.524.50% (-0.59)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -524.36 | 1.20 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.89 | 5.97 | 0.56% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Veerhealth Care is engaged in manufacturing and marketing research-based Ayurvedic medicines. The Company's product categories include Tablets, Syrups, Ointments, Powder, Oil and Toothpaste.
Peers
Compare with peersSUNPHARMA
PE Ratio
40.38
1Y Return
1.12%
Buy Reco %
85.29
CIPLA
PE Ratio
28.66
1Y Return
2.75%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
62.75
1Y Return
13.84%
Buy Reco %
68.00
DRREDDY
PE Ratio
16.73
1Y Return
12.31%
Buy Reco %
45.16
MANKIND
PE Ratio
48.73
1Y Return
4.48%
Buy Reco %
80.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.55 | 2.64 | 5.89 | 6.27 | 12.21 | 11.78 | 11.30 | 14.51 | 14.61 | 15.36 | ||||||||||
Raw Materials | 1.58 | 1.58 | 3.08 | 3.84 | 8.65 | 8.38 | 7.99 | 10.44 | 8.40 | 13.61 | ||||||||||
| Power & Fuel Cost | 0.08 | 0.08 | 0.11 | 0.10 | 0.22 | 0.25 | 0.20 | 0.20 | 0.24 | |||||||||||
| Employee Cost | 0.47 | 0.58 | 0.57 | 0.47 | 0.80 | 0.83 | 0.88 | 0.90 | 1.31 | |||||||||||
| Selling & Administrative Expenses | 0.65 | 0.26 | 0.46 | 0.49 | 0.62 | 0.48 | 0.78 | 0.90 | 0.72 | |||||||||||
| Operating & Other expenses | -0.58 | -0.22 | 1.07 | 0.64 | 0.76 | 0.58 | 0.59 | 0.33 | 1.94 | |||||||||||
EBITDA | 0.35 | 0.36 | 0.60 | 0.73 | 1.16 | 1.26 | 0.86 | 1.74 | 2.00 | 1.75 | ||||||||||
| Depreciation/Amortization | 0.21 | 0.23 | 0.27 | 0.32 | 0.32 | 0.47 | 0.52 | 0.62 | 0.71 | 0.82 | ||||||||||
| PBIT | 0.14 | 0.13 | 0.33 | 0.41 | 0.84 | 0.79 | 0.34 | 1.12 | 1.29 | 0.93 | ||||||||||
| Interest & Other Items | 0.13 | 0.10 | 0.07 | 0.03 | 0.19 | 0.22 | 0.09 | 0.00 | 0.01 | 0.12 | ||||||||||
| PBT | 0.01 | 0.03 | 0.26 | 0.38 | 0.65 | 0.57 | 0.25 | 1.12 | 1.28 | 0.81 | ||||||||||
| Taxes & Other Items | 0.02 | 0.01 | 0.11 | 0.22 | 0.33 | 0.20 | 0.31 | -0.46 | 0.88 | 0.86 | ||||||||||
| Net Income | -0.01 | 0.02 | 0.15 | 0.16 | 0.32 | 0.37 | -0.06 | 1.58 | 0.40 | -0.05 | ||||||||||
| EPS | -0.00 | 0.01 | 0.05 | 0.06 | 0.15 | 0.18 | -0.03 | 0.93 | 0.20 | -0.03 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
FY 2015
Annual report
PDFFY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Veerhealth Care Ltd | 65.55 | 1.20 | — |
| Sun Pharmaceutical Industries Ltd | 40.38 | 5.76 | 0.84% |
| Cipla Ltd | 28.66 | 4.41 | 0.89% |
| Torrent Pharmaceuticals Ltd | 62.75 | 15.16 | 0.91% |
Price Comparison
Compare VEERHEALTH with any stock or ETFCompare VEERHEALTH with any stock or ETF
VEERHEALTH
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
VEERHEALTH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Earnings
Veerhealth Care standalone net profit declines 63.16% in the December 2024 quarter
Net profit of Veerhealth Care declined 63.16% to Rs 0.07 crore in the quarter ended December 2024 as against Rs 0.19 crore during the previous quarter ended December 2023. Sales rose 33.80% to Rs 3.84 crore in the quarter ended December 2024 as against Rs 2.87 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales3.842.87 34 OPM %3.915.92 - PBDT0.320.41 -22 PBT0.070.23 -70 NP0.070.19 -63 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Veerhealth Care to conduct board meeting
Veerhealth Care will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Veerhealth Care standalone net profit declines 23.08% in the September 2024 quarter
Net profit of Veerhealth Care declined 23.08% to Rs 0.30 crore in the quarter ended September 2024 as against Rs 0.39 crore during the previous quarter ended September 2023. Sales rose 34.46% to Rs 5.15 crore in the quarter ended September 2024 as against Rs 3.83 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales5.153.83 34 OPM %9.325.48 - PBDT0.620.63 -2 PBT0.420.45 -7 NP0.300.39 -23 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Veerhealth Care to conduct board meeting
Veerhealth Care will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Veerhealth Care to convene AGM
Veerhealth Care announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Veerhealth Care standalone net profit declines 64.71% in the June 2024 quarter
Net profit of Veerhealth Care declined 64.71% to Rs 0.12 crore in the quarter ended June 2024 as against Rs 0.34 crore during the previous quarter ended June 2023. Sales declined 42.46% to Rs 2.06 crore in the quarter ended June 2024 as against Rs 3.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales2.063.58 -42 OPM %-0.9712.01 - PBDT0.340.58 -41 PBT0.150.40 -63 NP0.120.34 -65 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Veerhealth Care to declare Quarterly Result
Veerhealth Care will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Veerhealth Care expects Rs 100 crore revenue in upcoming 2-3 years
7 months agoBusiness Standard
Veerhealth Care secures new export order of Rs 89 lakh
7 months agoBusiness Standard
Stocks that will see action today: April 18, 2023
1 year agoThe Hindu Businessline
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 18.43%, vs industry avg of 9.04%
Constant Market Share
Over the last 5 years, market share stayed at 0%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 20.11%, vs industry avg of 15.27%